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Background: There is a lack of epidemiological data on COPD by disease severity. We
have estimated the prevalence and underdiagnosis of COPD by disease severity
defined by the British Thoracic Society (BTS) and Global Initiative for Chronic
Obstructive Lung Disease (GOLD) guidelines. The impact of smoking was evaluated
by the population attributable fraction of smoking in COPD.
Methods: A random sample of 1500 responders of the third postal survey performed
in 1996 of the Obstructive Lung Disease in Northern Sweden (OLIN) Studies’ first
cohort (6610 subjects recruited in 1985) were invited to structured interview and
spirometry. One thousand two hundred and thirty-seven subjects (82%) performed
spirometry.
Results: The prevalence of mild BTS-COPD was 5.3%, moderate 2.2%, and severe
0.6% (GOLD-COPD: mild 8.2%, moderate 5.3%, severe 0.7%, and very severe 0.1%). All
subjects with severe COPD were symptomatic, corresponding figures among mild
COPD were 88% and 70% (BTS and GOLD), Subjects with severe BTS-COPD reported a
physician-diagnosis consistent with COPD in 50% of cases, in mild BTS-COPD 19%,
while in mild GOLD-COPD only 5% of cases. The major risk factors, age and smoking,Elsevier Ltd. All rights reserved.
574 11 70; fax: +46 920 28 33 50.
med.se (A. Lindberg).
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COPD by disease severity and smoking attributable fraction 265had a synergistic effect on the COPD-prevalence. The Odds Ratio (OR) for having
COPD among smokers aged 76–77 years was 59 and 34 (BTS and GOLD) when non-
smokers aged 46–47 was used as reference population.
Conclusions: Most subjects with COPD have a mild disease. The underdiagnosis is
related to disease-severity. Though being symptomatic, only a half of the subjects
with severe COPD are properly labelled. Smoking and increasing age were the major
risk factors and acted synergistic.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Chronic obstructive pulmonary disease (COPD) is a
common and disabling disease and a growing cause
of mortality world wide.1–3 During 1990s, several
guidelines for management of COPD and diagnosing
the disease were developed, among them were the
British Thoracic Society (BTS) and the Global
Initiative for Chronic Obstructive Lung Disease
(GOLD) guidelines.1,2 The prevalence of COPD is
largely dependent on the age distribution of the
studied population samples, their smoking habits,
and which criteria for disease that has been used.4
Whereas numerous cross-sectional studies of re-
spiratory symptoms and diseases among young
people and adults up to middle ages have been
reported, there is still little data from studies
including lung function among middle aged and
elderly.5,6 Thus, there are still limited data about
prevalence of COPD according to recent guidelines
among middle-aged and elderly subjects, in whom
COPD is most common.7–9 Further, data about
disease severity and the size of the proportion of
subjects with COPD who never were smokers as
well are even more rare . Data from population
studies are needed in order to explore these topics,
as the slowly progressive nature of COPD1 means
that the disease usually remains undetected for
years.8–10
The Obstructive Lung Disease in Northern Sweden
(OLIN) Studies started in 1985–86,11 and now
several cohorts are under study. The age composi-
tion of the OLIN Studies first cohort, together with
the large participation rate, provides an opportu-
nity to study the epidemiology of COPD in relevant
ages. The third postal survey of the cohort was
performed in 1996 and was followed by structured
interviews and lung function tests. COPD was
strongly related to increasing age and smoking.8
The main aim of this study was to measure
prevalence and underdiagnosis of COPD by disease
severity as defined by BTS1 and GOLD guidelines2
and to assess the proportion of symptomatics by
degree of severity. Further aims were to study
combined effects of increasing age and smoking as
risk for COPD, and to evaluate the epidemiologicalconcept population attributable fraction (PAF) with
regard to smoking and COPD.Material and methods
Study population
A random sample of 1500 subjects living in the
northernmost province of Sweden was invited to
structured interviews and lung function tests in
1996, and 1237 (82%), 51% women, completed a
lung function test with acceptable technique.8 Of
women, 26% were current smokers versus 24% of
men, 47% of men were ex-smokers versus 24% of
women, while 51% of women were non-smokers
versus 29% of men. Smoking was most common
among subjects in the youngest age group both
among men and women.8
The study sample was drawn from the responders
of the postal questionnaire to the third survey12,13
of the OLIN Studies’ first cohort. The first survey of
the OLIN cohort I was performed in 1985/86. All
6610 subjects born in 1919–20, 1934–35, and
1949–1950 living in eight areas were invited.11 In
1996, 5892 subjects could be traced to the third
survey, and 5189 (88%) responses were received, or
79% of the original study cohort from 1985. The
study was approved by the Ethics Committee at
Umea˚ University.Methods
Structured interview
The interview questionnaire consisted of questions
about respiratory symptoms, use of medicines, past
and present smoking habits including exposure to
environmental tobacco smoke, occupation, socio-
economic group, and family history of obstructive
airway diseases (OADs).14 Questions about symp-
toms including cough, sputum production, wheez-
ing, and dyspnoea were included. The OLIN postal
questionnaire was developed from the original
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naire and has been used in several Northern
European studies,15,16 and has also previously been
described in detail.15,17
Lung function test
The lung function tests were performed by using a
dry spirometer (Mijnhardt Vicatest 5) by following
the ATS guidelines.18 Reference values reported by
Berglund19 were used, which conforms to the
symptom-free population of the OLIN Studies.14 A
reversibility test by using 4 0:2mg Ventoline
Discuss was performed in subjects with a ratio of
FEV1/FVC or VCo0.7, or FEV1o90% of predicted.
Definitions
COPD was classified according to the criteria
developed by BTS (1) and GOLD (2). GOLD define
COPD as FEV1/FVCo0.7, and BTS criteria include
both FEV1/FVCo0.7 and FEV1o80% of predicted
values. The GOLD criteria include lung function
after reversibility test, while the BTS criteria are
not clear on that point. The BTS criteria mention
both VC and FVC as denominators for the ratio. We
have used the values after reversibility test, and
the highest value of either VC or FVC. Further, BTS
states that asthma with chronic obstruction may be
included in COPD, while GOLD criteria do not
clearly recommend to distinguish between asthma
with chronic obstruction and COPD. Thus, subjects
with chronic obstruction who stated that they had
asthma have been included in the analyses.
The classification of smoking status was based on
the answers to questions regarding smoking habits
in the structured interview. Subjects who currently
smoked every week or had stopped smoking within
12 months prior to the study were classified as
smokers, while those who had stopped4than 12
months previously were classified as ex-smokers.
Ever smokers include current- and ex-smokers.
Never smokers refer to subjects who have never
been smokers, i.e. they are not current- or ex-
smokers.
Use of ‘‘airway medicines’’ included affirmative
answers to questions regarding regular or as-
needed use of beta-2-agonists and/or inhaled
anticholinergics and/or inhaled glukocorticoster-
eoids and/or expectorantia.
Grading of severity
The severity of COPD is defined by level of FEV1 in %
of predicted, and the grading of severity vary: BTSdefines severe COPD as FEV1o40% predicted,
moderate COPD as FEV1X40%o60% predicted and
mild COPD as FEV1X60%o80% predicted. GOLD
defines very severe disease as FEV1o30% pre-
dicted, severe COPD as FEV1X30%o50% predicted,
moderate COPD as FEV1X50%o80% predicted, and
mild COPD as FEV1480% predicted. Very severe
COPD according to GOLD includes also subjects with
FEV1X30%o50% predicted in case of having hypox-
emia. In the current study, blood gases were not
measured.
Analyses
Statistical analyses were performed using the
Statistical Package for the Social Sciences (SPSS).
w2-square test was used for bi-variate calculations.
Determinants for COPD were calculated by multiple
logistic regression analysis, in which the indepen-
dent variables were age, gender, smoking habits,
socio-economic group based on occupation,20 and
family history of OAD, i.e. of asthma, chronic
bronchitis, emphysema or COPD. Age groups and
smoking habits created a combined variable with
nine categories. Odds ratios (ORs) are reported
with 95% confidence intervals (CI). P-valueso0:05
were regarded statistically significant.
The risk difference (RD) or attributable risk for
ever smoking was calculated: risk exposed (ever
smoker) (Re)—risk un-exposed (never-smoker) (R0).
The population attributable risk (PAR) was calcu-
lated: RD prevalence of ever smoker (p), which is
the occurrence of the disease attributable to
exposure. The PAF is the fraction of all cases in
the population due to exposure and was calculated:
(prevalence of ever smoker (p)(Risk Ratio
(RR)1))/(1+p(RR1)).21,22Result
The prevalence of COPD was strongly smoking
dependent and increased considerably with in-
creasing age (Table 1). The prevalence of COPD
increased almost linear from the age of 47 years in
smokers, while in non-smokers the increase started
after the age of 62 years (Fig. 1).
COPD by disease severity
The distribution of the disease severity among the
subjects with COPD according to the BTS criteria
was: 65% mild disease, 27% moderate, and 8%
severe disease. The corresponding distribution of
COPD according to the GOLD criteria was: 57% mild,
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Table 1 Prevalence of COPD by age and smoking according to the BTS and GOLD criteria, respectively.
Criteria Category 46–47 years 61–62 years 76–77 years All Difference (P-value)
Age Smoking
GOLD Non-smoker 3 5 21 7.8
Ex-smokers 6 14 33 14.5
Smokers 11 42 50 24.6
Total 6.5 17.1 28.7 14.3 o0.001 o0.001
BTS Non-smokers 1 2 16 3.8
Ex-smokers 2 7 20 7.6
Smokers 5 24 45 14.1
Total 2.8 9.0 19.7 8.1 o0.001 o0.001
Difference (P-value) by age and smoking habits.
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Figure 1 Prevalence of COPD according to the BTS and GOLD criteria by age, in smokers and non-smokers.
COPD by disease severity and smoking attributable fraction 26737% moderate, 5% severe, and 1% very severe
disease (Fig. 2). Estimated at population level, the
prevalence of mild COPD according to BTS was
5.3%, moderate 2.2%, and severe 0.6%. Correspond-
ing prevalence rates according to GOLD were mild
COPD 8.2%, moderate 5.3%, severe 0.7%, and very
severe disease 0.1%.
Underdiagnosis and symptoms by disease
severity
Of the subjects fulfilling the criteria for COPD and
having FEV1o40% of predicted (severe COPD
according to BTS), 88% had chronic productive
cough, and 100% had either longstanding cough,
sputum production, recurrent wheeze, attacks of
shortness of breath, or dyspnoea of at least MRC
grade 2. Among them, 50% were diagnosed ashaving chronic bronchitis, emphysema, or any
labelling synonymous with COPD, and 100% used
airway medicines (Table 2). The corresponding
figures for mild COPD according to GOLD were as
follows: 21% reported chronic productive cough,
70% were symptomatic, and only 5% were diagnosed
as having chronic bronchitis, emphysema, or COPD,
and 10% were using airway medicines. Further,
among subjects with mild COPD according to GOLD,
18% were either using airway medicines, or
reported a diagnosis of chronic bronchitis, emphy-
sema, COPD, or asthma prior to the survey
(Table 2).
Multivariate relationships
The combined effects of age and smoking have
been explored more in detail by multiple logistic
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Figure 2 Prevalent cases of COPD according to the BTS and GOLD criteria, distribution by disease severity.
Table 2 Proportion (%) of diagnosed subjects, symptomatics, users of airway medicines or expectorantia,
including N-acetylcysteine, and self-reported obstructive airway disease (OAD) among subjects with COPD (FEV1/
VCo0.7) by different levels of FEV1.
Condition FEV1o40% of
predicted
FEV1 40–59% of
predicted
FEV1 60–79% of
predicted
FEV1X80% of
predicted
Symptomatics 100 91 88 70
Chronic productive Cough 88 63 51 21
Physician-diagnosed chronic
bronchitis, emphysema or COPD
50 28 19 5
Use of medicines 100 47 26 10
Use of medicines, or any self-
reported OAD
100 63 42 18
A. Lindberg et al.268regression analysis. Other independent variables
included in the multivariate model were gender,
socio-economic group based on occupation, and
family history of OAD. Gender was not significantly
associated with COPD, while family history of OAD
was significantly related with COPD according to
BTS. In comparison with non-smokers in the
subjects aged 46–47 years, the non-smokers aged
61–62 years yielded an OR of 1.36 for having COPD
according to BTS and of 2.09 for COPD according to
GOLD, both without reaching a significant differ-
ence. However, the effect of age was stronger
among non-smoking subjects aged 76–77 years, and
the OR for COPD according to BTS was 11.71 (95% CI
3.34–41.03), while it was 9.97 (95% CI 4.17–23.84)
for COPD according to GOLD (Table 3).
In smoking subjects aged 46–47 years, the OR was
3.38 (95% CI 0.90–12.69) for having COPD according
to BTS, while it was 4.48 (95% CI 1.89–10.65) for
COPD according to GOLD. The combined effect ofsmoking and age appeared highly significant among
subjects aged 61–62 years and yielded odds
rations420 for COPD according to both criteria.
The ORs for smokers aged 76–77 years were 58.96
and 33.66 (COPD according to BTS and GOLD,
respectively), and both highly significant compared
with non-smokers aged 46–47 years. The combined
effect of increasing age and smoking illustrates a
multiplicative effect (Table 3).COPD and smoking
In subjects with COPD according to BTS 76% were
ever smokers (GOLD 77%), and the proportion was
89% among men (GOLD 84%) and 64% in women
(GOLD 68%) (Table 4). All men with severe COPD
according to BTS were smokers or ex-smokers,
while 86% with moderate and 90% with mild COPD
were smokers or ex-smokers. In all subjects with
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Table 3 Risk factors (Odds ratios, OR and 95% confidence intervals, CI) for COPD according to GOLD (COPD-
GOLD) and BTS (COPD-BTS) criteria, respectively, by multiple logistic regression analysis.
Independent variables Dependent variables
COPD-GOLD COPD-BTS
OR 95% CI OR 95% CI
Sex
Men 1 1
Women 1.12 0.66–1.88 1.32 0.72–2.23
Family history of OAD
No 1 1
Yes 1.33 0.92–1.95 1.94 1.21–3.12
Age and smoking habits combined
Age 46–47 years, non-smoker 1 1
Age 46–47 years, ex-smoker 2.35 0.94–5.92 1.43 0.32–6.50
Age 46–47 years, smoker 4.48 1.89–10.65 3.38 0.90–12.69
Age 61–62 years, non-smoker 2.09 0.81–5.35 1.36 0.30–6.15
Age 61–62 years, ex-smoker 5.84 2.46–13.87 5.41 1.48–19.85
Age 61–62 years, smoker 22.02 9.45–51.34 20.97 6.15–71.43
Age 76–77 years, non-smoker 9.97 4.17–23.84 11.71 3.34–41.03
Age 76–77 years, ex-smoker 15.75 6.59–37.66 17.2 4.84–61.07
Age 76–77 years, smoker 33.66 10.53–107.58 58.96 13.82–251.48
The independent variables include sex, family history of obstructive airway disease (OAD), and the combination of smoking
habits and age-class.
Table 4 Proportions of ever smokers (prop %)
among subjects with COPD according to the BTS
and GOLD in men and women.
Criteria Category Prop (%) PAF PARy
COPD-BTS All 76 41 0.033
Men 89 64 0.050
Women 64 29 0.025
COPD by disease severity and smoking attributable fraction 269COPD (BTS) in the age groups 46–47 years, 81% were
ever smokers, and in those aged 61–62 years 90%
(GOLD 85% in both age groups), while in the age
group 76–77 years it was 62–61% according to both
criteria. The corresponding figures among women
with COPD according to BTS were 83% in severe,
69% in moderate and 59% in mild disease. The
proportion of smokers and ex-smokers was similar
by disease severity of COPD according to GOLD.COPD-GOLD All 77 43 0.073
Men 84 46 0.087
Women 68 37 0.056
Population attributable fraction (PAF) and population
attributable risk (PAR) of ever smoking in COPD.
Attributable fraction in the study population, percent.
yPopulation attributable risk.Attributable fraction and population
attributable risk
The PAF of ever smoking in COPD according to BTS
was 41% (men 64%, women 29%). The corresponding
figures for COPD according to GOLD were similar
but yielded somewhat smaller gender differences
(Table 4). Further, the PAR of ever smoking in COPD
was calculated (Table 4). The fraction of COPD
according to BTS in the population attributable to
ever smoking was also calculated by age, and was in
subjects aged 46–47 years 47% (GOLD 58%), in those
aged 61–62 years 76% (GOLD 65%), while it was
lower in the elderly aged 76–77 years, 21% (GOLD
22%).Discussion
In order to further deepen the knowledge of the
descriptive epidemiology of COPD, we have exam-
ined the prevalence and underdiagnosis of COPD by
disease severity. In addition to calculation of single
risk factors for COPD, the risk combination of
increasing age and smoking and the PAR of ever
smoking in COPD were estimated. We have
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major risk factors in the same age-stratified sample
of the general population.8
The major findings of this study are that
increasing age and smoking are the two dominating
risk factors for COPD. Among men, 89% were
current or ex-smokers of the subjects fulfilling the
spirometric criteria (BTS) for COPD. The proportion
of never smokers among subjects classified as
having COPD (BTS) was somewhat greater than
expected among women, 36%. These findings will
be further discussed. Secondly, although the
majority of subjects suffering from COPD had a
mild disease, a large proportion of this popula-
tion445 years, 3–6%, had a moderate or severe
COPD.
There are limited data in the literature about
COPD by disease severity. The overall prevalence of
COPD in Northern Sweden conforms well to results
from large studies in USA, Spain, Italy and Nor-
way.7,9,23,24 Regarding disease severity, the pre-
valence of mild COPD was 5.3% (BTS)–8.2% (GOLD),
or similar to the 6.9% according to GOLD found in
the US NHANES III survey.25 Moderate, severe and
very severe COPD according to GOLD was in our
study 6.1% versus 6.6% in the NHANES III. Analyses
of NHANES I from 1970s found severe and very
severe COPD with FEV1o50% of predicted normal
value to be 1.7% in the US population,26 and this
proportion was similar 20 years later9 and some-
what higher than in our study, in which it was 0.9%.
Distribution by severity of incident COPD (GOLD)
over 15 years in the Copenhagen City Heart Study
conforms also well with the overall impression;
mild COPD accounted for 7.2%, moderate for 5.8%,
and severe for 0.2%.27 The prevalence of severe
COPD (i.e. identical with severe BTS according to
the later published BTS Guidelines) in Bergen,
Norway, was 0.2% compared with 0.6% in our
study.23 We have to keep in mind that the average
age particularly in the NHANES and the Norwegian
studies were younger than in our study. Further, the
very low proportion of severe COPD in this cross-
sectional setting has to be studied also prospec-
tively, as it may reflect poor survival.
Only 20–30% of the subjects fulfilling the criteria
for COPD had been correctly identified prior to the
study. The underdiagnosis of COPD was related to
disease severity. In severe COPD according to BTS
every other subject had a diagnosis consistent with
COPD, and they all reported respiratory symptoms.
Of subjects with mild disease (GOLD), only 5% were
diagnosed as having chronic bronchitis, emphyse-
ma, or labellings synonymous with COPD, while 18%
either used medicines for the airways or reported
any diagnosis of a respiratory disease. The overalldegree of underdiagnosis conforms to previous
findings.9,10,28
The combined effect of smoking and age, as
given in uncorrected estimates of prevalence in
Fig. 1, and in terms of adjusted odds ratios in Table
3, is the largely dominating determinant of COPD in
a cross-sectional setting. The studied sample
consisted of middle-aged and elderly, and the
majority of smokers have been smoking since
decades. The average age of start of smoking was
14 years.11 It would have been an advantage if the
exposure could have been expressed in quantitative
terms as pack-years. However, retrospective as-
sessments of pack-years are accompanied with
uncertainty, and dividing the smokers by exposure
categories would have enlarged the already very
wide confidence intervals. Analysis of cotinine
levels can increase the strength of data on
smoking-status, but no lab-tests were performed
in this study. Though a recall bias on previous
smoking history is known (mainly underestimating
previous smoking), it is considered reliable to use
self-reported smoking status in population-based
studies.29,30
Smoking and increasing age are the major risk
factors for COPD, and among men with severe COPD
all were current or ex-smokers. Some of the women
fulfilling the criteria of COPD reported no history of
smoking, most frequent among elderly women,
aged 76–77 years, and women with mild COPD (63%
and 41%, respectively). The overall non-smoking
cases of COPD were most commonly found in
elderly aged 76–77 years. The strong relationship
between smoking and COPD found in this study was
on a similar level as reported by the NHANES III,26
while in the Copenhagen City Heart Study the
association with smoking and COPD was found to be
weaker.27
Non-smokers with COPD has only rarely been
studied, but have been recognised among others by
Siafakas et al.31 Smoking was more common in the
past in Sweden and most Nordic countries as well.
Environmental tobacco smoke may contribute to
COPD in non-smokers,32 but also overall airborne
exposure over the lifetime and a low socio-
economic status.23 However, among the elderly
the combination of normal ageing and the use of
the fixed ratio defining COPD contribute to an
overestimation of COPD.6 This may have a major
impact on the proportion of non-smokers among
subjects defined as having COPD as the majority
were elderly subjects with mild COPD. There is a
need for further studies on this sub-population of
elderly never smokers in order to clarify to which
extent there is an overestimation of COPD, in how
many cases asthma contributes to a chronic
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having COPD or can be considered respiratory
healthy. After taking these questions into account,
further analysis of risk factors for COPD among non-
smokers could be evaluated. It is already known
that the proportion of subjects with alpha-1-anti-
trypsine deficiency is not big enough to have any
major influence on population level.33
Close to 90% of men with COPD were smokers or
ex-smokers and age is an important risk factor, but
also other risk factors as the total amount of
airborne exposure contributes to COPD. However,
smoking can almost be regarded as a necessary risk
factor for COPD, especially among subjects with
severe COPD. The PAF include evaluation of and
correction for several risk factors contributing to a
disease. PAF is regarded as a measure of the public
health impact of a certain exposure, while it is a
function of the potential harm of the exposure
(through the relative risk) and how common the
exposure is (through its prevalence, in this study
proportion of ever-smokers). It has been used in
evaluating occupational exposure in COPD.34 The
PAF in COPD of ever smoking express the proportion
of the population with COPD that is or has been
attributed to smoking. Our results demonstrate the
importance of smoking as the PAF of smoking in
COPD increased to almost 80% in ages 61–62 years
but it was less in the elderly (76–77 years). The
probable explanation of the decreased importance
of smoking in elderly is the use of the fixed ratio for
the definition of airway obstruction. As previously
discussed, the spirometric criteria of COPD with a
fixed quotient will overestimate COPD among
elderly and include also non-smokers without
respiratory symptoms.6 Further, as stated in the
section definition, patients with chronic obstruc-
tion due to asthma but fulfilling the spirometric
criteria of COPD were not excluded, and we can
expect that asthma contributed to some of the non-
smoking cases of COPD. The guidelines definition of
COPD1,2 does not exclude asthma as a cause of
chronic obstruction, and the proportion of non-
smokers in COPD, though low, has to be interpreted
in accordance. The PAF of smoking in COPD has to
be evaluated in relation to factors as age, defini-
tion of COPD, disease severity, but also concomi-
tant asthma, otherwise the public health impact of
smoking in COPD may be underestimated.
In this epidemiological study, the data collected
were based on structured interview and spirometry
and the diagnosis of COPD was based on spirometric
criteria. The results are to be interpreted in
accordance with the methods used. The diagnosis
and possible overestimation of COPD among elderly
has been discussed here and also by others.6Further, the possible heterogeneity of subjects
classified as having mild COPD, especially among
elderly, has to be surveyed and is also an important
area for future epidemiological studies. PAF is a
well-known epidemiological concept, but pre-
viously hardly used in the aspect of describing the
impact of smoking in COPD. It is of importance to
increase the knowledge in the descriptive epide-
miology of COPD, but also important, as discussed,
to evaluate both the strength and weakness when
using new methods.
In conclusion, in a cross-sectional setting, the
majority of subjects with COPD irrespective of
criteria had mild COPD, but almost a half had a
moderate or severe COPD. The small proportion
having severe COPD may reflect a poor survival and
has to be studied longitudinally. Smoking and
increasing age are the dominating risk factors for
COPD. The PAF of smoking for COPD was close to
80% in ages 61–62 years. However, PAF was related
to age and is most probably related also to disease
severity and needs further evaluation with respect
to these factors when assessing the public health
impact of smoking in COPD.Acknowledgements
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